The following table shows the list of Horizon 2020 projects developed by "INSTITUT JULES BORDET". Projects are ordered by starting date.
Click on table headers to rearrange data.
# | acronym | programme | role | EC contrib. | start | views |
---|---|---|---|---|---|---|
1 | MyPeBS | H2020-EU.3.1.3. | participant | 660˙000.00 | 2018-01-01 | 1078 |
2 | IMMUcan | H2020-EU.3.1.7. | participant | 20˙000.00 | 2019-03-01 | 323 |
3 | oncNGS | H2020-EU.3.1.5. | participant | 300˙375.00 | 2020-01-01 | 790 |
totale | 980˙375.00 |
This organization collaborated with partners in 11 countries.
Within the project MyPeBS this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | BE | INTUITIM | INTUITIM (PRC) |
participant | FR | Predilife | PREDILIFE (PRC) |
participant | FR | INVS | AGENCE NATIONALE DE SANTE PUBLIQUE (PUB) |
participant | FR | CNGE | COLLEGE NATIONAL DES GENERALISTES ENSEIGNANTS (OTH) |
participant | UK | ICPV | INDEPENDENT CANCER PATIENTS' VOICE (OTH) |
participant | IT | im3D | IM3D SPA (PRC) |
participant | FR | FONDATION ARC | FONDATION ARC POUR LA RECHERCHE SUR LE CANCER (REC) |
participant | IT | AUSL-IRCCS | AZIENDA UNITA SANITARIA LOCALE DI REGGIO EMILIA (PUB) |
participant | BE | EONIX | EONIX (PRC) |
participant | IT | AOU TO | AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO (PUB) |
participant | IL | Assuta | ASSUTA MEDICAL CENTERS LTD (PRC) |
coordinator | FR | UNICANCER | UNICANCER (REC) |
participant | BE | ECL | ASSOCIATION EUROPEENNE DES LIGUES CONTRE LE CANCER ASBL (OTH) |
participant | FR | CEPH | FONDATION JEAN DAUSSET CENTRE D'ETUDE DU POLYMORPHISME HUMAIN FONDATION (REC) |
participant | IT | ISPRO | ISTITUTO PER LO STUDIO E LA PREVENZIONE E LA RETE ONCOLOGICA (OTH) |
participant | IT | IRST | ISTITUTO SCIENTIFICO ROMAGNOLO PERLO STUDIO E LA CURA DEI TUMORI SRL (REC) |
participant | FR | IGR | INSTITUT GUSTAVE ROUSSY (REC) |
participant | US | UC | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (HES) |
participant | FR | UP13 | UNIVERSITE PARIS 13 (HES) |
participant | UK | QMUL | QUEEN MARY UNIVERSITY OF LONDON (HES) |
participant | FR | UCBL | UNIVERSITE LYON 1 CLAUDE BERNARD (HES) |
participant | UK | UNIMAN | THE UNIVERSITY OF MANCHESTER (HES) |
participant | UK | UoN | THE UNIVERSITY OF NOTTINGHAM (HES) |
participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
participant | NL | ERASMUS | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
participant | UK | FEL | LOUGHBOROUGH UNIVERSITY (HES) |
participant | FR | CEA | COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (REC) |
Within the project IMMUcan this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | LCC | LIGUE NATIONALE CONTRE LE CANCER (REC) |
participant | FR | OWKIN | OWKIN FRANCE (PRC) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | US | AbbVie | ABBVIE INC (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | BE | DDUV | DE DUVE INSTITUTE (REC) |
participant | FR | PIERRE FABRE | INSTITUT DE RECHERCHE PIERRE FABRESAS (PRC) |
participant | FR | CLB | CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD (REC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | LU | LIH | LUXEMBOURG INSTITUTE OF HEALTH (REC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
coordinator | BE | EORTC | EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL (REC) |
participant | ES | CRG | FUNDACIO CENTRE DE REGULACIO GENOMICA (REC) |
participant | CH | CHUV | CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS (PUB) |
participant | CH | SIB | SIB INSTITUT SUISSE DE BIOINFORMATIQUE (REC) |
participant | FR | IC | INSTITUT CURIE (REC) |
participant | UK | UoB | THE UNIVERSITY OF BIRMINGHAM (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | CH | UZH | UNIVERSITAT ZURICH (HES) |
participant | IL | WEIZMANN | WEIZMANN INSTITUTE OF SCIENCE (HES) |
participant | UK | KCL | KING'S COLLEGE LONDON (HES) |
participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | DE | CHA | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project oncNGS this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | BE | DCP-IP | DE CLERCQ & PARTNERS (PRC) |
coordinator | BE | Sciensano | SCIENSANO (REC) |
participant | ES | AQuAS | AGENCIA DE QUALITAT I AVALUACIO SANITARIES DE CATALUNYA (OTH) |
participant | ES | IBSAL | FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON (REC) |
participant | BE | BCR | STICHTING KANKERREGISTER - FONDATION REGISTRE DU CANCER (REC) |
participant | ES | VHIO | FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON (REC) |
participant | ES | ICO | INSTITUT CATALA D'ONCOLOGIA (REC) |
participant | FR | HCL | HOSPICES CIVILS DE LYON (PUB) |
participant | IT | ACC | ALLEANZA CONTRO IL CANCRO (OTH) |
participant | FR | IC | INSTITUT CURIE (REC) |
participant | FR | INCa | INSTITUT NATIONAL DU CANCER GIP (PUB) |
participant | DE | LMU MUENCHEN | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (HES) |
participant | DE | CHARITE | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |